Recruiting

Genetic Frontotemporal Dementia

Sponsor:

Western University

Code:

NCT05779813

Conditions

Frontotemporal Dementia

Family Members

Eligibility Criteria

Sex: All

Age: 7 - 17

Healthy Volunteers: Accepted

Study Details

Brief summary:

This is an international multi-centre cohort study of first and second degree family members of individuals who carry Frontotemporal Dementia (FTD) mutations in MAPT, GRN or C9ORF72 repeat expansions for youths between the ages 9-17.

Conditions

Frontotemporal Dementia

Family Members

Study ID

NCT05779813

Start date

Mar 31, 2023

Status verified date

Mar, 2025

Completion date

Mar, 2035

Anticipated

Primary completion date

Mar, 2033

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 7 - 17

Healthy Volunteers: Accepted

Inclusion Criteria:

1. Written informed consent must be obtained and documented (from the participant and their substitute decision maker). This can be obtained in person or remotely.
2. Youths between the ages of 9 and 16 inclusive at time of enrollment, followed until age 17.
3. Youths must have a 1st or 2nd degree biological relative who has participated (past or present) in the Genetic Frontotemporal Dementia Initiative (GENFI) study or with genetic FTD (i.e. a known mutation in biological parent or grandparent).
4. Parent(s)/guardian deem appropriate to participate.
5. Must have a study partner who can participate as required in the protocol (provide corroborative information). Study partner must have regular contact with the participant and must be parent/guardian of this participant.
6. Must have age-appropriate awareness that FTD runs in their family as determined by local PI.

Exclusion Criteria:

1. Current structural brain abnormality affecting cognition or behaviour not thought to be possibly related to genetic FTD that would prevent completion of study assessments (such as brain tumor, stroke, hydrocephalus).
2. Other concerns that participation in the study may not be in the best interest of the youth or parent, as raised by the participant's parent/guardian/primary care provider, local site PI or psychologist.
3. Lack of study partner.
4. For MRI: meeting any MRI incompatible criteria. Note: Participants may opt to decline MRI scans and complete the other measures.

Study Design

Enrollment

200 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • Brain development as measured by structural and functional Magnetic Resonance Imaging [ Time Frame: Through study completion, an average of 2 years ]

Central Contacts and Locations

Locations

Western University

Recruiting

London, Ontario, Canada, N6A 3K7

Contacts

More Information

Sponsor

Western University

Last update posted

Apr 3, 2025

Last verified

Mar, 2025

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Western University on 2025-04-03.